Who owns Array BioPharma?

Key details on Array BioPharma (Ticker: ARRY)

Who owns Array BioPharma?

Is ARRY a good stock to own? Find out who bought Array BioPharma, who sold Array BioPharma (ARRY) stock, and who holds a large position in Array BioPharma.

Fund Name Number of Shares Share Valuation As Of
FMR 18.50M $133.36M June 30, 2015
Redmile 13.13M $96.74M March 31, 2015
Deerfield Management Company 11.83M $87.22M March 31, 2015
OrbiMed Advisors 10.33M $76.15M March 31, 2015
BVF 9.17M $66.11M June 30, 2015
T. Rowe Price Associates 7.61M $56.07M March 31, 2015
Vanguard 6.31M $45.53M June 30, 2015
Baker Bros. Advisors 5.66M $41.71M March 31, 2015
STATE STREET CORPORATION 5.65M $40.76M June 30, 2015
BlackRock Fund Advisors 5.17M $37.27M June 30, 2015
Artal Group S.A. 4.01M $28.91M June 30, 2015
BlackRock Institutional Trust Company, N.A. 3.86M $27.82M June 30, 2015
Gail Mannix 3.82M $27.54M June 30, 2015
TimesSquare Capital Management 3.79M $27.29M June 30, 2015
Kopp Investment Advisors 3.59M $16.29M June 30, 2013
QVT Financial 3.44M $15.61M June 30, 2013
Apex Capital 3.10M $11.07M Sept. 30, 2014

Who sold Array BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
Columbia Wanger Asset Management June 30, 2011 4.40M $9.85M